Total Payments
$1,081
2024 Payments
$343.52
Companies
12
Transactions
58
Medicare Patients
2,537
Medicare Billing
$137,445
Payment Breakdown by Category
Food & Beverage$1,081 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,081 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $438.93 | 25 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $221.83 | 12 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $121.67 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $70.67 | 4 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $69.91 | 1 | $0 (2022) |
| RedHill Biopharma Inc. | $50.62 | 4 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $22.98 | 1 | $0 (2023) |
| EVOKE PHARMA, INC. | $21.63 | 1 | $0 (2021) |
| Amgen Inc. | $18.81 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $17.39 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $343.52 | 18 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($170.78) |
| 2023 | $373.13 | 21 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($109.93) |
| 2022 | $248.72 | 12 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($115.32) |
| 2021 | $115.51 | 7 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($42.90) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Gastroenterology | ||||||
| 08/28/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Gastroenterology | ||||||
| 06/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/17/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Gastroenterology | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Gastroenterology | ||||||
| 05/08/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 05/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Gastroenterology | ||||||
| 04/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Gastroenterology | ||||||
| 02/15/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 01/25/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 01/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Gastroenterology | ||||||
| 12/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Gastroenterology | ||||||
| 12/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Gastroenterology | ||||||
| 12/04/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/03/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Gastroenterology | ||||||
| 10/30/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/26/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 949 | 7,338 | $1.0M | $48,882 |
| 2022 | 4 | 686 | 5,030 | $766,550 | $37,465 |
| 2021 | 4 | 481 | 4,749 | $565,150 | $26,991 |
| 2020 | 4 | 421 | 4,634 | $517,450 | $24,107 |
Total Patients
2,537
Total Services
21,751
Medicare Billing
$137,445
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Office | 2023 | 261 | 264 | $448,925 | $24,210 | 5.4% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Office | 2023 | 145 | 145 | $287,375 | $16,338 | 5.7% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Office | 2023 | 77 | 77 | $133,925 | $7,709 | 5.8% |
| J2704 | Injection, propofol, 10 mg | Office | 2023 | 466 | 6,852 | $171,300 | $625.78 | 0.4% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Office | 2022 | 179 | 180 | $310,950 | $17,213 | 5.5% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Office | 2022 | 104 | 104 | $215,000 | $12,342 | 5.7% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Office | 2022 | 72 | 72 | $123,750 | $7,433 | 6.0% |
| J2704 | Injection, propofol, 10 mg | Office | 2022 | 331 | 4,674 | $116,850 | $476.95 | 0.4% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Office | 2021 | 101 | 101 | $209,325 | $12,109 | 5.8% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2021 | 99 | 100 | $165,550 | $9,230 | 5.6% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 41 | 43 | $77,650 | $5,200 | 6.7% |
| J2704 | Injection, propofol, 10 mg | Office | 2021 | 240 | 4,505 | $112,625 | $451.55 | 0.4% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2020 | 94 | 94 | $160,500 | $9,453 | 5.9% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Office | 2020 | 71 | 71 | $157,975 | $8,678 | 5.5% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 51 | 52 | $88,550 | $5,599 | 6.3% |
| J2704 | Injection, propofol, 10 mg | Office | 2020 | 205 | 4,417 | $110,425 | $377.08 | 0.3% |
About Andrew Griffin, CRNA
Andrew Griffin, CRNA is a Nurse Anesthetist, Certified Registered healthcare provider based in Belleville, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790761252.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Andrew Griffin, CRNA has received a total of $1,081 in payments from pharmaceutical and medical device companies, with $343.52 received in 2024. These payments were reported across 58 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,081).
As a Medicare-enrolled provider, Griffin has provided services to 2,537 Medicare beneficiaries, totaling 21,751 services with total Medicare billing of $137,445. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Anesthetist, Certified Registered
- Other Specialties Certified Registered|Nurse Anesthetist, Certified Registered
- Location Belleville, IL
- Active Since 12/16/2005
- Last Updated 01/14/2020
- Taxonomy Code 367500000X
- Entity Type Individual
- NPI Number 1790761252
Products in Payments
- XIFAXAN (Drug) $438.93
- OCALIVA (Drug) $221.83
- ENTYVIO (Biological) $121.67
- DIFICID (Drug) $70.67
- AJOVY (Biological) $69.91
- Talicia (Drug) $24.84
- DUPIXENT (Biological) $22.98
- GIMOTI (Drug) $21.63
- AMJEVITA (Biological) $18.81
- TREMFYA (Drug) $17.39
- IDACIO (Biological) $13.36
- ZENPEP (Drug) $13.08
- Movantik (Drug) $13.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Anesthetist, Certified Registered Doctors in Belleville
Vanessa Voudrie, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $221.42
Nurse Anesthetist, Certified Registered $221.42
Mary Gonzales, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $179.71
Nurse Anesthetist, Certified Registered $179.71
Dr. Kevin Stein, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $137.62
Nurse Anesthetist, Certified Registered $137.62
Mr. Danny Geib, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $136.75
Nurse Anesthetist, Certified Registered $136.75
Julianna Compton, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $134.69
Nurse Anesthetist, Certified Registered $134.69
Todd Littlejohn, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $113.97
Nurse Anesthetist, Certified Registered $113.97